Tactile Systems Stock Price, News & Analysis

Tactile Systems Technology, Inc. (Nasdaq: TCMD), a medical technology company specializing in at-home treatment devices for chronic diseases, will announce its second quarter fiscal year 2021 financial results on August 2nd, after market close. A conference call hosted by management will take place at 5:00 p.m. ET the same day, with a Q&A session. Participants can join via phone or through a live webcast on the company's investor relations website. Tactile Medical focuses on home therapy devices for conditions like lymphedema and chronic venous insufficiency to improve patient care and reduce healthcare costs.

Tactile Systems Technology (Nasdaq: TCMD) announced its participation in the William Blair 41st Annual Growth Stock Conference from June 1-3, 2021. The company will host a fireside chat on June 1 at 8:40 a.m. Central Time. A live audio webcast will be available on their investor relations website, with an archive for replay post-conference. Tactile Medical specializes in at-home therapy devices for chronic conditions like lymphedema, aiming to enhance patient care and reduce healthcare costs.

Tactile Systems Technology, Inc. (TCMD) reported its Q1 2021 financial results, showing a 2% decrease in total revenue to $42.8 million year-over-year. The operating loss improved slightly to $4.1 million, while net loss increased to $2.3 million. The company maintained a cash position of $46.9 million. Despite challenges from COVID-19, management expects a recovery in Q2 and reaffirms the 2021 revenue outlook of $215.3 million to $224.5 million, indicating a potential 15%-20% growth. New appointments to the board and management aim to strengthen operations.

Tactile Medical (NASDAQ: TCMD) announced Eric Pauls as the new Senior Vice President of Sales, effective May 1, 2021, succeeding retiring Bryan Rishe. Pauls brings over 20 years of healthcare experience, having previously held senior roles at Royal Philips. His expertise includes building successful teams and expanding markets, particularly in chronic diseases like lymphedema and sleep apnea. Tactile Medical specializes in at-home therapy devices, aiming to improve patient care and reduce healthcare costs.

Tactile Systems Technology (Nasdaq: TCMD) announced it will release its first quarter 2021 financial results after market close on May 3. The management team will host a conference call at 5:00 p.m. ET to discuss these results. Participants can dial in using 877-407-3088 (or 201-389-0927 for international) with access code 13718669. A live webcast will also be available on the investor relations section of Tactile Medical's website. The company specializes in at-home treatment devices for chronic conditions like lymphedema.

Tactile Systems Technology, Inc. (Nasdaq: TCMD) announced Kristie Burns as the new Senior Vice President of Marketing & Clinical Affairs, effective March 22, 2021. Burns, who has over 25 years of experience in the healthcare sector, succeeds Darren Wennen, now Senior VP of Commercial Operations. Previously, Burns held executive roles at Cala Health and ResMed, focusing on chronic condition treatments. Tactile Medical aims to enhance its market penetration under her leadership, which could improve access to critical therapies for patients with chronic diseases.

Tactile Systems Technology (TCMD) reported a 4% increase in fourth-quarter revenue for 2020, reaching $59.2 million, compared to $57.1 million in Q4 2019. The net income surged to $12.1 million, a significant rise from $4.3 million a year earlier. However, overall revenue for the year decreased by 1% to $187.1 million. Despite facing challenges from the COVID-19 pandemic, the company aims for a 15% to 20% revenue growth in 2021, forecasting total revenue between $215.3 million and $224.5 million. Cash and equivalents stood at $47.9 million at year-end.

Tactile Systems Technology, Inc. (Nasdaq: TCMD) announced participation in two upcoming investor conferences.

Management will engage in a virtual fireside chat on February 17 at 9:30 a.m. ET during the BTIG Virtual MedTech Conference. Additionally, they will present at the Oppenheimer 31st Annual Healthcare Conference on March 16 at 10:40 a.m. ET.

Audio webcasts will be accessible on the company’s investor relations website and available for replay after the events.

Tactile Medical specializes in home therapy devices for chronic diseases, focusing on improving patient care and reducing healthcare costs.

Tactile Systems Technology (TCMD) will release its fourth quarter and fiscal year 2020 financial results after market close on February 23, 2021. Management will host a conference call at 5:00 p.m. ET on the same day to discuss the financial outcomes and answer questions from participants. Investors can join the call via phone or through a live webcast on their investor relations website. The archived call will be available for two weeks, ensuring that shareholders can review the details of the financial performance and strategic insights shared during the event.